GlycoDepot
GlycoDepot

Galα1-4Galβ1-4Glc 

Galα1-4Galβ1-4Glc (α1,4-galactobiose extended lactose, also called globotriaose precursor) represents a blood group B-related trisaccharide and Shiga toxin rece…

Galα1-4Galβ1-4Glc 
Pricing
Request a quote

Size

Quantity

  • ISO 9001:2015 facilities · CoA + batch tracking with every shipment
  • Worldwide shipping · dry-ice option for thermolabile reagents
  • Research Use Only — not for human or veterinary clinical use

About this product

Galα1-4Galβ1-4Glc  (α1,4-galactobiose extended lactose, also called globotriaose precursor) represents a blood group B-related trisaccharide and Shiga toxin receptor analog, appearing as a white lyophilized powder essential for bacterial pathogenesis studies and glycan array standards. This linear carbohydrate, featuring rare α1-4 galactosyl linkage on the non-reducing Galβ1-4Glc core, serves as a high-affinity ligand for Shiga-like toxins (SLT-I/II) from E. coli O157:H7, blocking cytotoxicity in vitro; absent in humans but prevalent in porcine/bovine gut epithelium, it is chemoenzymatically synthesized (>98% purity) using α1-4 galactosyltransferase, demonstrating gastric stability, selective E. coli galactosidase hydrolysis, and roles in microbiome modulation, vaccine development against HUS, and cancer glycomimetic design, with multi-year ambient stability. Appearance White to off-white amorphous lyophilized powder, odorless. Highly water-soluble (>300 g/L); forms clear solutions at neutral pH. ​ Source Found in pig/small ruminant intestinal glycosphingolipids; microbial Gb3 precursors. Enzymatic synthesis via α4GalT on lactose using UDP-Gal donors. ​ Molecular Weight and Structure 504.44 g/mol, formula C₁₈H₃₂O₁₆ (trisaccharide sodium salt). α-D-Galp-(1→4)-β-D-Galp-(1→4)-D-Glcp linear chain. ​ Sugar Specificity Binds Shiga toxin B-subunits (KD 10⁻⁹ M); recognized by blood group B lectins. Hydrolyzed by α1-4 galactosidases from Bacteroides fragilis. ​ Biological Activity Neutralizes SLT cytotoxicity; modulates Gb3 synthase pathway. Prebiotic for Gb3-utilizing probiotics; anti-adhesive against EHEC. ​ Purity and Microbial Contamination ≥98% by HPLC/NMR; endotoxins <5 EU/mg post-purification. Sterile, heavy metals <1 ppm, moisture <4% lyophilized. ​ Identity and Quality Control ¹H-NMR (α1-4 H-1 doublet 5.2 ppm); LC-MS [M+Na]⁺ 527.2. HPAEC-PAD confirms Gal:Gal:Glc 2:1:1 ratio. ​ Shelf Life and Storage 36+ months at -20°C or ambient desiccated. Protect from humidity to avoid hydrolysis. ​ Applications Shiga toxin neutralization assays; HUS vaccine adjuvants. Glycan microarray standards; blood group B research. ​ Key Characteristics Ultra-high toxin affinity; heat-stable to 100°C. Linear scaffold for Gb4/Gb5 extensions. ​ Citation Links https://www.vulcanchem.com/product/VC212766 ​ https://pubchem.ncbi.nlm.nih.gov/compound/91859346 ​ https://www.smolecule.com/products/s1817995 ​ https://orthandex.com/info/56537.html ​ https://www.vulcanchem.com/product/vc212723 ​ https://pubchem.ncbi.nlm.nih.gov/compound/91847904 ​ https://www.chemsrc.com/en/cas/157240-67-0_654751.html ​ http://chemsynlab.com/en/product/41744-59-6.html ​ https://pmc.ncbi.nlm.nih.gov/articles/PMC2271034/ ​ https://pubchem.ncbi.nlm.nih.gov/compound/Gal-alpha1-4-Gal-beta1-4-Glc

You may also need

LNnDFH II

LNnDFH II

Lacto-N-neodifucohexaose II (LNnDFH II, Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4Glc) represents an ultra-rare difucosylated type 2 chain huma…

Quote on requestIn stock